Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,147
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
for
Sarcoma,Soft Tissue
Location: Philadelphia PA, New Haven CT, Toronto, Durham NC,
Sponsor: Intensity Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06263231
Phase3, Recruiting
Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)
for
Stroke
Location: Philadelphia PA, Camden NJ
Sponsor: Temple University
Sex: All
Age: 18+
Code: NCT06530693
Recruiting
Biological Effects of Quercetin in COPD
for
Chronic Obstructive Pulmonary Disease
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 40 - 70+
Code: NCT03989271
Phase1, Phase2, Recruiting
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Philadelphia PA, Hackensack NJ, Baltimore MD,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT06714591
Phase1, Recruiting
Duet 2.0 Starting the Conversation: A New Intervention Model to Stimulate Language Growth in Underserved Populations
for
Language Development, Language, Child, Early Intervention
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 1+
Code: NCT04692519
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Brief Behavioral Sleep Intervention for Obesity Prevention in Primary Care
for
Obesity, Childhood, Short Sleep, Obesity Prevention
Location: Philadelphia PA
Sponsor: Temple University
Sex: All
Age: 6 - 11
Code: NCT06810557
Recruiting
Combination Tissue Plasminogen Activator (Tpa) and Dornase Alfa (Dnase) Administration Through Intrapleural Catheters for the Treatment of Loculated or Non-Draining Malignant Pleural Effusions
for
Loculated or Non-draining Malignant Pleural Effusions
Location: Philadelphia PA
Sponsor: Eastern Regional Medical Center
Sex: All
Age: 18 - 70+
Code: NCT02135588
Phase1, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Philadelphia PA, Cherry Hill NJ, Sewell NJ, Newark DE,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Philadelphia PA, Cherry Hill NJ, Sewell NJ, New York NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
WellSpan-THRIVE Cancer QOL Study
for
Cancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative,
Location: Ephrata PA, Lebanon PA, York PA, Gettysburg PA,
Sponsor: WellSpan Health
Sex: All
Age: 18+
Code: NCT07433660
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability